Caplin Point Laboratories Statistics
Total Valuation
Caplin Point Laboratories has a market cap or net worth of INR 182.31 billion. The enterprise value is 175.13 billion.
Market Cap | 182.31B |
Enterprise Value | 175.13B |
Important Dates
The last earnings date was Thursday, November 7, 2024.
Earnings Date | Nov 7, 2024 |
Ex-Dividend Date | Sep 23, 2024 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | -0.10% |
Shares Change (QoQ) | +0.09% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 19.31M |
Valuation Ratios
The trailing PE ratio is 36.94.
PE Ratio | 36.94 |
Forward PE | n/a |
PS Ratio | n/a |
PB Ratio | n/a |
P/TBV Ratio | 7.42 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 28.97, with an EV/FCF ratio of 75.82.
EV / Earnings | 35.48 |
EV / Sales | 9.56 |
EV / EBITDA | 28.97 |
EV / EBIT | 32.19 |
EV / FCF | 75.82 |
Financial Position
The company has a current ratio of 6.07, with a Debt / Equity ratio of 0.00.
Current Ratio | 6.07 |
Quick Ratio | 4.53 |
Debt / Equity | 0.00 |
Debt / EBITDA | 0.00 |
Debt / FCF | 0.01 |
Interest Coverage | 937.91 |
Financial Efficiency
Return on equity (ROE) is 21.24% and return on invested capital (ROIC) is 14.52%.
Return on Equity (ROE) | 21.24% |
Return on Assets (ROA) | 12.74% |
Return on Capital (ROIC) | 14.52% |
Revenue Per Employee | 5.38M |
Profits Per Employee | 1.45M |
Employee Count | 3,406 |
Asset Turnover | 0.69 |
Inventory Turnover | 2.37 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +70.52% in the last 52 weeks. The beta is 0.41, so Caplin Point Laboratories's price volatility has been lower than the market average.
Beta (5Y) | 0.41 |
52-Week Price Change | +70.52% |
50-Day Moving Average | 2,110.51 |
200-Day Moving Average | 1,673.93 |
Relative Strength Index (RSI) | 60.79 |
Average Volume (20 Days) | 230,016 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Caplin Point Laboratories had revenue of INR 18.33 billion and earned 4.94 billion in profits. Earnings per share was 64.65.
Revenue | 18.33B |
Gross Profit | 10.45B |
Operating Income | 5.44B |
Pretax Income | 6.14B |
Net Income | 4.94B |
EBITDA | 6.03B |
EBIT | 5.44B |
Earnings Per Share (EPS) | 64.65 |
Balance Sheet
The company has 8.27 billion in cash and 24.30 million in debt, giving a net cash position of 8.24 billion.
Cash & Cash Equivalents | 8.27B |
Total Debt | 24.30M |
Net Cash | 8.24B |
Net Cash Per Share | n/a |
Equity (Book Value) | 25.75B |
Book Value Per Share | 324.91 |
Working Capital | 16.69B |
Cash Flow
In the last 12 months, operating cash flow was 3.75 billion and capital expenditures -1.44 billion, giving a free cash flow of 2.31 billion.
Operating Cash Flow | 3.75B |
Capital Expenditures | -1.44B |
Free Cash Flow | 2.31B |
FCF Per Share | n/a |
Margins
Gross margin is 57.02%, with operating and profit margins of 29.68% and 26.93%.
Gross Margin | 57.02% |
Operating Margin | 29.68% |
Pretax Margin | 33.52% |
Profit Margin | 26.93% |
EBITDA Margin | 32.92% |
EBIT Margin | 29.68% |
FCF Margin | 12.60% |
Dividends & Yields
This stock pays an annual dividend of 5.00, which amounts to a dividend yield of 0.22%.
Dividend Per Share | 5.00 |
Dividend Yield | 0.22% |
Dividend Growth (YoY) | 11.11% |
Years of Dividend Growth | 10 |
Payout Ratio | 7.69% |
Buyback Yield | 0.10% |
Shareholder Yield | 0.32% |
Earnings Yield | 2.70% |
FCF Yield | n/a |
Stock Splits
The last stock split was on October 19, 2016. It was a forward split with a ratio of 5.
Last Split Date | Oct 19, 2016 |
Split Type | Forward |
Split Ratio | 5 |
Scores
Altman Z-Score | n/a |
Piotroski F-Score | n/a |